Josiah D Rich
Biographic Data
| ID | 6061912 |
|---|---|
| NAME | Josiah D Rich |
| GIVEN NAMES | Josiah D |
| FAMILY NAME | Rich |
| SIGNATURE | RICH J D |
| AFFILIATIONS | Brown University |
| ORCID | 0000-0002-4517-7841 |
| VERIFIED | Yes |
| TOTAL WORKS | 67 |
| TOTAL CITATIONS | 39 |
| AUTHOR COUNT | 67 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 1996 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 3 |
Xylazine Awareness and Suspected Presence in the Illicit Drug Supply Among People Who Used Stimulants in an Overdose Hotspot, 2023
Background Xylazine is harmful to humans and detected in the United States fentanyl supply and sometimes in stimulants. Awareness of xylazine among people who use stimulants (PWUS) is underexplored.Methods In 2023, 59 PWUS in Brockton, Massachusetts, were surveyed about their past 30-day substance use and xylazine awareness. A purposive sub-sample of 21 survey participants completed an in-depth interview, of which 18 discussed xylazine. Chi-squar…
Business and Service Provider Attitudes Towards Police Involvement in Overdose Response
Criminalizing Serious Mental Illness
The United States has responded to multiple societal ills, from substance use to homelessness to mental health, with criminalization. A new analysis using City and County of San Francisco data shows jails disproportionately harm people with serious mental illness (SMI). In addition to longer periods of incarceration and higher rates of repeat jail bookings, people with SMI also experience higher rates of homelessness, co-occurring substance use d…
Hepatitis C treatment in a jail setting
Jail-based HCV treatment initiation is feasible. However, individuals released with medication face challenges in linkage to care. Improved discharge planning and community linkage are critical to post-release treatment success
Self-reported pathways through which illicitly manufactured fentanyl enters the stimulant supply
Background: The unintentional consumption of stimulants containing fentanyl among people who intend to only use stimulants contributes to overdose mortality in North America. Research exploring how fentanyl appears in the stimulant supply among people who manufacture and/or distribute drugs (PWDD) is critical to understanding supply-side factors that shape stimulant and opioid-involved overdose risk. Methods: From April to July 2023, thirty PWDD …
How do US orthopaedic surgeons view placebo-controlled surgical trials? A pilot online survey study
Randomised placebo-controlled trials (RPCTs) are the gold standard for evaluating novel treatments. However, this design is rarely used in the context of orthopaedic interventions where participants are assigned to a real or placebo surgery. The present study examines attitudes towards RPCTs for orthopaedic surgery among 687 orthopaedic surgeons across the USA. When presented with a vignette describing an RPCT for orthopaedic surgery, 52.3% of pa…
U.S. policy responses to xylazine
Attitudes of Black American Christian church leaders toward Opioid Use Disorder, overdoses, and harm reduction
Black American Christian church leaders are a critical resource in providing innovative and culturally sensitive strategies in the opioid overdose crisis affecting the Black American communities. As such, their views should be carefully considered in OUD policies, collaborations, and interventions in the Black American community
Preventing overdoses involving stimulants
Completion of this study will yield a rich understanding of the social epidemiology of stimulant and opioid-involved overdoses in addition to community-derived intervention strategies that can be readily implemented and scaled to prevent such overdoses in two states disproportionately impacted by the opioid and overdose crises: Massachusetts and Rhode Island
Reimbursing incarcerated individuals for participation in research
Xylazine in the drug supply
Cruel and Unusual
A Decentralized Model for Supervised Consumption Services
Drug use behaviors, trauma, and emotional affect following the overdose of a social network member
Switching of opioid agonist treatment modality during imprisonment
Reports of accidental fentanyl overdose among police in the field
The Lived Experience of Managing HIV and Chronic Pain
Optimizing the impact of medications for opioid use disorder at release from prison and jail settings
Expanding Mail-Based Distribution of Drug-Related Harm Reduction Supplies Amid Covid-19 and Beyond
Expanding Mail-Based Distribution of Drug-Related Harm Reduction Supplies Amid COVID-19 and Beyond Brian S. Barnett MD, Sarah E. Wakeman MD, Corey S. Davis JD, MSPH, Jamie Favaro MSW, and Josiah D. Rich MD, MPH Affiliation Brian S. Barnett is with the Department of Psychiatry and Psychology, Center for Behavioral Health, Neurological Institute, Cleveland Clinic, Cleveland, OH. Sarah E. Wakeman is with the Division of General Internal Medicine, Ma…
Flattening the Curve for Incarcerated Populations — Covid-19 in Jails and Prisons
Flattening the Curve for Incarcerated Populations People caught up in the U.S. justice system have already been affected by SARS-CoV-2, and improved preparation is essential to minimizing the impac...
Emergency department utilization by people living with HIV released from jail in the US South
Modeling Covid-19 and Its Impacts on U.S. Immigration and Customs Enforcement (ICE) Detention Facilities, 2020
Falling Through the Cracks
The protective effect of trusted dealers against opioid overdose in the U.S
An Overlooked Crisis
Prevalence and Incidence of HIV, Hepatitis B Virus, and Hepatitis C Virus Infections Among Males in Rhode Island Prisons
Objectives. We evaluated prevalence and intraprison incidence of HIV, hepatitis B virus, and hepatitis C virus infections among male prison inmates. Methods. We observed intake prevalence for 4269 sentenced inmates at the Rhode Island Adult Correctional Institute between 1998 and 2000 and incidence among 446 continuously incarcerated inmates (incarcerated for 12 months or more). Results. HIV, hepatitis B virus, and hepatitis C virus prevalences w…
An Overlooked Crisis
A Missed Opportunity
In 2003, the Centers for Disease Control and Prevention issued recommendations to screen all inmates with a history of injection drug use or other risk factors for hepatitis C. We compared self-reported risk factors for hepatitis C with serostatus from inmates in the Rhode Island Department of Corrections. Of the male inmates who were hepatitis C positive, 66% did not report injection drug use. Risk-based testing underestimates the hepatitis C vi…
Physicians’ Knowledge of and Willingness to Prescribe Naloxone to Reverse Accidental Opiate Overdose
A Budget Impact Analysis of Newly Available Hepatitis C Therapeutics and the Financial Burden on a State Correctional System
Medicaid Policies and Practices in US State Prison Systems
Medicaid is an important source of health care coverage for prison-involved populations. From 2011 to 2012, we surveyed state prison system (SPS) policies affecting Medicaid enrollment during incarceration and upon release; 42 of 50 SPSs participated. Upon incarceration, Medicaid benefits were suspended in 9 (21.4%) SPSs and terminated in 28 (66.7%); 27 (64.3%) SPSs screened prisoners for potential Medicaid eligibility. Although many states suppo…
Increasing Hepatitis C Prevalence and Associated Risk Behaviors among Incarcerated Young Adults
Attitudes and Practices Regarding the Use of Methadone in US State and Federal Prisons
Expanding Mail-Based Distribution of Drug-Related Harm Reduction Supplies Amid Covid-19 and Beyond
Expanding Mail-Based Distribution of Drug-Related Harm Reduction Supplies Amid COVID-19 and Beyond Brian S. Barnett MD, Sarah E. Wakeman MD, Corey S. Davis JD, MSPH, Jamie Favaro MSW, and Josiah D. Rich MD, MPH Affiliation Brian S. Barnett is with the Department of Psychiatry and Psychology, Center for Behavioral Health, Neurological Institute, Cleveland Clinic, Cleveland, OH. Sarah E. Wakeman is with the Division of General Internal Medicine, Ma…
The First Comprehensive Program for Opioid Use Disorder in a US Statewide Correctional System
AffiliationsJennifer G. Clarke is with the Rhode Island Department of Corrections, Cranston, RI. Rosemarie A. Martin and Shelley A. Gresko are with the Brown University School of Public Health, Providence, RI. Josiah D. Rich is with the Warren Alpert Medical School of Brown University and the Miriam Hospital, Providence, RI
Transitions to Care in the Community for Prison Releasees with HIV
Pharmacist and Pharmacy Staff Experiences with Non-prescription (NP) Sale of Syringes and Attitudes Toward Providing HIV Prevention Services for Injection Drug Users (IDUs) in Providence, RI
Addressing the Hiv Epidemic Through Quality Correctional Healthcare
A prison release program for HIV-positive women
A prison release program for HIV-positive women: linking them to health services and community follow-up. T P Flanigan, J Y Kim, S Zierler, J Rich, K Vigilante, and D Bury-MaynardCopyRight https://doi.org/10.2105/AJPH.86.6.886 Published Online: October 07, 2011
A prison release program for HIV-positive women
A prison release program for HIV-positive women: linking them to health services and community follow-up. T P Flanigan, J Y Kim, S Zierler, J Rich, K Vigilante, and D Bury-MaynardCopyRight https://doi.org/10.2105/AJPH.86.6.886 Published Online: October 07, 2011
Successful linkage of medical care and community services for HIV-positive offenders being released from prison
Syringe access for the prevention of blood borne infections among injection drug users
By assisting illicit drug injectors to obtain sterile syringes the primary care provider is able to reduce the incidence of blood borne infections, and educate patients about safe syringe disposal. The provider is also able to initiate discussion about drug use in a nonjudgmental manner and to offer care to patients who are not yet ready to consider drug treatment
A comparison of syringe prescription and syringe exchange in Rhode Island, USA
A Syringe Prescription Program to Prevent Infectious Disease and Improve Health of Injection Drug Users
Hepatitis C infection and incarcerated populations
Prevalence and Incidence of HIV, Hepatitis B Virus, and Hepatitis C Virus Infections Among Males in Rhode Island Prisons
Objectives. We evaluated prevalence and intraprison incidence of HIV, hepatitis B virus, and hepatitis C virus infections among male prison inmates. Methods. We observed intake prevalence for 4269 sentenced inmates at the Rhode Island Adult Correctional Institute between 1998 and 2000 and incidence among 446 continuously incarcerated inmates (incarcerated for 12 months or more). Results. HIV, hepatitis B virus, and hepatitis C virus prevalences w…
Attitudes and Practices Regarding the Use of Methadone in US State and Federal Prisons
A Missed Opportunity
In 2003, the Centers for Disease Control and Prevention issued recommendations to screen all inmates with a history of injection drug use or other risk factors for hepatitis C. We compared self-reported risk factors for hepatitis C with serostatus from inmates in the Rhode Island Department of Corrections. Of the male inmates who were hepatitis C positive, 66% did not report injection drug use. Risk-based testing underestimates the hepatitis C vi…
Addressing the Hiv Epidemic Through Quality Correctional Healthcare
Physicians’ Knowledge of and Willingness to Prescribe Naloxone to Reverse Accidental Opiate Overdose
A model of integrated primary care for HIV-positive patients with underlying substance use and mental illness
There is a high burden of underlying substance use and mental illness in HIV-infected populations. HIV-care settings provide an important opportunity to assess substance and mental health needs among HIV-positive patients and to provide or make referrals for appropriate treatment services. In 2003, with funding from the Center for Substance Abuse Treatment (CSAT), we developed a model of integrated substance-use counselling and referral for treat…
Health Issues in Prisons and Jails
Health Issues in Prisons and Jails
Health Issues in Prisons and Jails
Substance Use, Mental Health Problems, and Behavior at Risk for HIV
This study examined the relationships between substance abuse, mental health problems and HIV risk behavior in offenders discharged from prison and referred to substance abuse treatment programs. Data from 34 sites (n = 1,358) in a federally-funded cooperative agreement, the Criminal Justice Drug Abuse Treatment Studies (CJDATS), were analyzed. Among parolees referred to substance abuse treatment, self reports for the six-month period before the …
Literature in Brief
Attitudes toward Methadone among Out-of-Treatment Minority Injection Drug Users
Injection drug use (IDU) continues to be a significant public health issue in the U.S. and internationally, and there is evidence to suggest that the burden of injection drug use and associated morbidity and mortality falls disproportionately on minority communities. IDU is responsible for a significant portion of new and existing HIV/AIDS cases in many parts of the world. In the U.S., the prevalence of HIV and hepatitis C virus is higher among p…
Pharmacist and Pharmacy Staff Experiences with Non-prescription (NP) Sale of Syringes and Attitudes Toward Providing HIV Prevention Services for Injection Drug Users (IDUs) in Providence, RI
Public Health and the Epidemic of Incarceration
An unprecedented number of Americans have been incarcerated in the past generation. In addition, arrests are concentrated in low-income, predominantly nonwhite communities where people are more likely to be medically underserved. As a result, rates of physical and mental illnesses are far higher among prison and jail inmates than among the general public. We review the health profiles of the incarcerated; health care in correctional facilities; a…
Syringe Acquisition Experiences and Attitudes among Injection Drug Users Undergoing Short-Term Opioid Detoxification in Massachusetts and Rhode Island
Hispanics, Incarceration, and TB/HIV Screening
Rapid HIV Testing for Individuals on Probation/Parole
Increasing Hepatitis C Prevalence and Associated Risk Behaviors among Incarcerated Young Adults
Medicaid Policies and Practices in US State Prison Systems
Medicaid is an important source of health care coverage for prison-involved populations. From 2011 to 2012, we surveyed state prison system (SPS) policies affecting Medicaid enrollment during incarceration and upon release; 42 of 50 SPSs participated. Upon incarceration, Medicaid benefits were suspended in 9 (21.4%) SPSs and terminated in 28 (66.7%); 27 (64.3%) SPSs screened prisoners for potential Medicaid eligibility. Although many states suppo…
Medicine (56 works) · Psychiatry (32 works) · HIV, Drug Use, Sexual Risk (30 works) · Psychology (29 works) · Family medicine (27 works) · Opioid Use Disorder Treatment (27 works) · Environmental health (21 works) · Nursing (19 works) · Political science (19 works) · Criminology (17 works)